A microbial signature for Crohn's disease

Kaynakça (3)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. [CrossRef ] Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6. [CrossRef ] Gevers D, Kugathasan S, Denson LA, et al. The treatment naive mi- crobiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-92. [CrossRef ] Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiata in Crohn's disease revealed by a metagenom- ic approach. Gut 2006; 55: 205-11. [CrossRef ] Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 2016: pii: gutjnl-2015-310746.
2. Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin in Crohn's disease. Am J Gastroenterol 2010; 105: 2420- 8. [CrossRef ] Coretti L, Natale A, Cuomo M, et al. The interplay between defen- sins and microbiata in Crohn's disease. Mediators Inflamm 2017; 2017: 8392523. [CrossRef ] Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn's disease. Gut 2017; pii: gutjnl-2016-313235.
3. Santiago A, Panda S, Mengels G, et al. Processing faecal samples: a step forward for standarts in microbial community analysis. BMC Microbiol 2014; 14: 112. [CrossRef ]